ReShape Lifesciences (RSLS) Q4 2024 Earnings

14NovConfirmed
Q3 2023
Q2 2024
Q3 2024
Q4 2024
-6.96
-4.69
-2.43
-0.16

Details

Expected EPS
-5.8
Actual EPS
-3.023531
Surprise EPS
2.78
Surprise Percent
+47.87%

Description

ReShape Lifesciences (RSLS) has reported earnings of -3.023531 per share for Q4 2024.

0 Comments

Share your thoughts